VECTOR BIOSCIENCE CAMBRIDGE LTD

13564111
Active London

Research and experimental development on biotechnology

6 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
V

VECTOR BIOSCIENCE CAMBRIDGE LTD

13564111

Research and experimental development on biotechnology

Founded 13 Aug 2021 Active London, England 6 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 29 Aug 2025 Next due 31 May 2026 20 days overdue
Confirmation Submitted 12 Aug 2025 Next due 26 Aug 2026 2 months remaining
Net assets £33K £49K 2024 year on year
Total assets £417K £242K 2024 year on year
Total Liabilities £383K £193K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

20-22 Wenlock Road London N1 7GU England

Email

info@example.com

Website

www.example.com

Full company profile for VECTOR BIOSCIENCE CAMBRIDGE LTD (13564111), an active life sciences and medical technology company based in London, England. Incorporated 13 Aug 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Sept → 31 Aug 2024
Type total-exemption-full
Next accounts 31 Aug 2025
Due by 31 May 2026 1 month overdue

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

£213.08k

Increased by £69.41k (+48%)

Net Assets

£33.26k

Increased by £49.05k (+311%)

Total Liabilities

£383.33k

Increased by £193.19k (+102%)

Turnover

N/A

Employees

6

Increased by 3 (+100%)

Debt Ratio

92%

Decreased by 17 (-16%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Aug Year End
2023
31 Aug Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 63,829 Shares £6.383 Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
31 Oct 202363,829£6.383£0

Officers

Officers

3 active
Status
David Fairen-jimenezDirectorSpanishUnited Kingdom4613 Aug 2021Active
Jogchum BrinksmaDirectorDutchUnited Kingdom5713 Aug 2021Active
Lluna Gallego SegrellesDirectorSpanishUnited Kingdom4413 Aug 2021Active

Shareholders

Shareholders (4)

Lluna Gallego Segrelles
40.4%
430,000
David Fairen-jimenez
39.5%
420,000

Persons with Significant Control

Persons with Significant Control (2)

2 Active 1 Ceased

David Fairen-jimenez

Spanish

Active
Notified 13 Aug 2021
Residence United Kingdom
DOB December 1979
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Lluna Gallego Segrelles

Spanish

Active
Notified 13 Aug 2021
Residence United Kingdom
DOB September 1981
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Jogchum Brinksma

Ceased 21 Aug 2024

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
29 Aug 2025AccountsAnnual accounts made up to 31 Aug 2024
12 Aug 2025Confirmation StatementConfirmation statement made on 12 Aug 2025 with updates
21 Aug 2024Persons With Significant ControlCessation of Jogchum Brinksma as a person with significant control on 21 Aug 2024
21 Aug 2024Persons With Significant ControlChange to Dr David Fairen-Jimenez as a person with significant control on 21 Aug 2024
15 Aug 2024Confirmation StatementConfirmation statement made on 12 Aug 2024 with updates
29 Aug 2025 Accounts

Annual accounts made up to 31 Aug 2024

12 Aug 2025 Confirmation Statement

Confirmation statement made on 12 Aug 2025 with updates

21 Aug 2024 Persons With Significant Control

Cessation of Jogchum Brinksma as a person with significant control on 21 Aug 2024

21 Aug 2024 Persons With Significant Control

Change to Dr David Fairen-Jimenez as a person with significant control on 21 Aug 2024

15 Aug 2024 Confirmation Statement

Confirmation statement made on 12 Aug 2024 with updates

Recent Activity

Latest Activity

Annual accounts made up to 31 Aug 2024

9 months ago on 29 Aug 2025

Confirmation statement made on 12 Aug 2025 with updates

10 months ago on 12 Aug 2025

Cessation of Jogchum Brinksma as a person with significant control on 21 Aug 2024

1 years ago on 21 Aug 2024

Change to Dr David Fairen-Jimenez as a person with significant control on 21 Aug 2024

1 years ago on 21 Aug 2024

Confirmation statement made on 12 Aug 2024 with updates

1 years ago on 15 Aug 2024